Evidence mapPaperPMID 41208100Full record

ReviewMini reviews in medicinal chemistry2026

Exploring the Potential of Anacardic Acid, its Natural and Synthetic Analogues, and Nanoformulations as a Potential Antibacterial Agent, including Multidrug-resistant Bacteria: A Comprehensive Review.

Priyabrata Pattanayak, Ananya Pradhan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Mini reviews in medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Priyabrata PattanayakSchool of Pharmacy, Faculty of Pharmaceutical Sciences, Siksha 'O' Anusandhan University, Bhubaneswar, 751003, Odisha, India.ORCID 0000-0003-4035-1182
Ananya PradhanSchool of Pharmacy, Faculty of Pharmaceutical Sciences, Siksha 'O' Anusandhan University, Bhubaneswar, 751003, Odisha, India.ORCID 0009-0002-8361-4472

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing rise of multidrug-resistant bacteria necessitates an urgent need for the discovery of novel antibacterial agents. Natural products have long been a source for identifying and isolating novel antibacterial agents. Anacardic acids (AAs), a phenolic lipid isolated from solventextracted cashew nutshell liquid (CNSL) of Anacardium occidentale (Family Anacardiaceae), have garnered potential attention for their potent antibacterial properties. Besides Anacardium occidentale, different analogues of AAs have also been isolated from various natural sources. These natural and structurally optimized derivatives exhibited potential antibacterial properties against other bacterial strains. Although AAs are associated with a high level of antimicrobial activity against

Indexed as

Anacardic AcidsAnti-Bacterial AgentsBacteriaBiological ProductsDrug Resistance, Multiple, BacterialNanoparticlesAnacardiumHumansMicrobial Sensitivity Testsanacardic acidAnacardic AcidsAnti-Bacterial AgentsBiological ProductsAnacardic acidantibacterial agentsgram-negative bacteriagram-positive bacteriamulti-resistant bacteriananoformulationsstructure-antibacterial study

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.